Question 1

Does Bank of New York Mellon own RCKT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Bank of New York Mellon holds 259,809 shares of RCKT (Rocket Pharmaceuticals), worth $888,548.

Question 2

How many shares of RCKT does Bank of New York Mellon own?

Accepted Answer

As of its Q2 2026 13F, Bank of New York Mellon holds 259,809 shares of RCKT (Rocket Pharmaceuticals).

Question 3

What is Bank of New York Mellon's RCKT position worth?

Accepted Answer

As of its Q2 2026 13F, Bank of New York Mellon's RCKT position is worth $888,548.

Question 4

Is Bank of New York Mellon buying or selling RCKT?

Accepted Answer

In Q2 2026, Bank of New York Mellon increased its RCKT position by 19,967 shares (+8.3%).

Question 5

When did Bank of New York Mellon first buy RCKT?

Accepted Answer

Bank of New York Mellon already held RCKT in its Q3 2019 13F, the earliest on record, and has listed it in 28 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	259,809	+8.3%	$888,548	0.0%	$3.42	27
2026-Q1	Decreased	239,842	-4.4%	$858,636	0.0%	$3.58	0
2025-Q4	Increased	250,962	+2.3%	$880,878	0.0%	$3.51	25
2025-Q3	Increased	245,313	+5.7%	$799,721	0.0%	$3.26	26
2025-Q2	Increased	231,986	+10.5%	$568,366	0.0%	$2.45	27
2025-Q1	Increased	209,967	+8.1%	$1.4M	0.0%	$6.67	28
2024-Q4	Increased	194,182	+5.4%	$2.4M	0.0%	$12.57	28
2024-Q3	Decreased	184,233	-23.2%	$3.4M	0.0%	$18.47	0